Retraction Note to: Extranuclear ERα is associated with regression of T47D PKCα-overexpressing, tamoxifen-resistant breast cancer
- Bethany Perez White†1,
- Mary Ellen Molloy†1,
- Huiping Zhao1,
- Yiyun Zhang2 and
- Debra A. Tonetti1Email author
© The Author(s). 2017
Received: 11 July 2017
Accepted: 11 July 2017
Published: 17 July 2017
The original article was published in Molecular Cancer 2013 12:34
This article  has been retracted by the authors after they discovered an error in the data. The authors recently performed Short Tandem Repeat (STR) analysis on all of their cell lines and discovered that the cell clone T47D:A18/PKCα is in fact MCF-7/PKCα. They have verified this using next generation sequencing of the p53 mutation that is a hallmark of T47D cells. All other cell lines reported in this article are as originally described. As a result of this error, parts of the article are inaccurate which affects the article’s conclusions. The authors will be given the opportunity to resubmit their corrected data.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.